or Try an Advanced Search...

    Technical Analysis for ACIU - AC Immune SA

    Grade Last Price % Change Price Change
    F 4.65 17.13% 0.68
    ACIU closed up 17.13 percent on Friday, May 31, 2024, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    Earnings due: Jun 21
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ACIU trend table...
    Date Alert Name Type % Chg
    Expansion Breakout Bullish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Parabolic Rise Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Gapped Up Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    180 Bullish Setup Bullish Swing Setup 17.13%
    Wide Bands Range Expansion 17.13%
    Older End-of-Day Signals for ACIU ...

       Recent Intraday Alerts

    Alert Time
    Bullish 180 Entry 2 days ago
    Rose Above Previous Day's High 2 days ago
    Rose Above Upper Bollinger Band 2 days ago
    1.5x Volume Pace 2 days ago
    Up 5% 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ACIU Chart by TradingView
    Basic chart:

    Profile

    AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimer’s and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinson's, and focuses on producing therapeutic and diagnostic product candidates, using SupraAntigen and Morphomer technology platforms. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn, among others.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biology Organ Systems Imaging Alzheimer's Disease Parkinson's Disease Neurological Disorders Dementia Neurodegenerative Diseases Psychiatric Diagnosis Glaucoma Degenerative Disease Neurodegeneration Imaging Agent Amyloid Beta Company's Pipeline

    Is ACIU a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 21 Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company
    May 13 Sector Update: Health Care Stocks Mixed Late Afternoon
    May 13 Top Midday Gainers
    May 13 Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
    May 13 Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
    May 13 AC Immune rockets 47% on Alzheimer's therapy deal with Takeda
    May 13 Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune
    May 13 Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate
    May 13 AC Immune GAAP EPS of -$0.18 misses by $0.03
    May 13 AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
    See more ACIU news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.14
    52 Week Low 1.9
    Average Volume 1,002,030
    200-Day Moving Average 3.23
    50-Day Moving Average 2.87
    20-Day Moving Average 3.22
    10-Day Moving Average 3.64
    Average True Range 0.33
    RSI (14) 78.17
    ADX 41.86
    +DI 43.66
    -DI 7.86
    Chandelier Exit (Long, 3 ATRs) 3.80
    Chandelier Exit (Short, 3 ATRs) 3.27
    Upper Bollinger Bands 4.50
    Lower Bollinger Band 1.94
    Percent B (%b) 1.06
    BandWidth 79.54
    MACD Line 0.37
    MACD Signal Line 0.24
    MACD Histogram 0.1288
    Fundamentals Value
    Market Cap 459.43 Million
    Num Shares 98.8 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -4.95
    Price-to-Sales 284765.75
    Price-to-Book 1.86
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.48
    Resistance 3 (R3) 5.43 5.10 5.34
    Resistance 2 (R2) 5.10 4.89 5.13 5.29
    Resistance 1 (R1) 4.88 4.76 4.99 4.93 5.25
    Pivot Point 4.55 4.55 4.61 4.58 4.55
    Support 1 (S1) 4.33 4.34 4.44 4.37 4.05
    Support 2 (S2) 4.00 4.21 4.03 4.01
    Support 3 (S3) 3.78 4.00 3.96
    Support 4 (S4) 3.82